Ninety One (UK)’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$61.7M Buy
434,881
+434,610
+160,373% +$69.9M 0.14% 107
2026
Q2
$45.7K Buy
+271
New +$40.2K ﹤0.01% 253

Other funds holding NBIX

Ninety One (UK)'s NBIX Position: Q3 2026 in Review

Ninety One (UK) increased its Neurocrine Biosciences (NBIX) stake by 160,373% in Q3 2026, buying an estimated $69.9M and bringing the position to 434,881 shares worth $61.7M. The position accounts for 0.14% of the portfolio, ranked #107.

Ninety One (UK) first reported a position in NBIX in Q2 2026 and has held it in 2 quarters since. 642 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.

  • Ninety One (UK) held 434,881 shares of Neurocrine Biosciences worth $61.7M as of Q3 2026.
  • Ninety One (UK) bought 434,610 Neurocrine Biosciences shares in Q3 2026, an estimated $69.9M.
  • Neurocrine Biosciences made up 0.14% of Ninety One (UK)'s portfolio in Q3 2026, its #107 holding.
  • Ninety One (UK) first reported a position in Neurocrine Biosciences in Q2 2026 and has held it in 2 quarters since.
  • 642 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.

Based on Ninety One (UK)'s 13F filing for Q3 2026, filed 15 Oct 2026.